Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review

Langerhans cell histiocytosis (LCH) is a rare neoplastic disease characterized by infiltration of histiocytes and dendritic cells into body organs. While treatment is better established in pediatrics, there is still no consensus on therapy in the adult population. Imatinib has shown promising result...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulgayoom, Mohammed, Mudawi, Deena, Lengyel, Zsolt, Abo Samra, Hayan, Alshurafa, Awni, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355039/
https://www.ncbi.nlm.nih.gov/pubmed/37476563
http://dx.doi.org/10.1159/000531230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355039/
https://www.ncbi.nlm.nih.gov/pubmed/37476563
http://dx.doi.org/10.1159/000531230

Ejemplares similares